Recursion Pharmaceuticals, Inc. is rated a Sell due to cash burn, Q3 net loss of $162.25M and operational trends. Learn more ...

Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Forbes contributors publish independent expert analyses and insights. We set an example for a better future via education and research. The possible shift back to entirely in-person work has sparked a ...

(KRON) — With the government shutdown that began on Oct. 1 about to enter its second month, dozens of government programs are already being impacted with further disruptions on the horizon. With ...

Approximately 3.4 million Texans are eligible for benefits through the Supplemental Nutrition Assistance Program (SNAP), a government program providing assistance to low-income households in need of ...

Forbes contributors publish independent expert analyses and insights. Amir is Founder of AI unicorn Avathon & Boeing/SC JV, SkyGrid. Recently, a friend asked me a question that's been floating around ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

The popular skincare product is said to help with acne, wrinkles, and dark spots. Here's what the science says. By Clarissa Brincat Published Sep 2, 2025 9:00 AM EDT Image: DepositPhotos Get the ...

The error message is really bad, because we don't show it in the VS Code extension. Error: Unexpected error: File "plugin/syntax_extension/PulseSyntaxExtension ...

Alaska Airlines is shuffling the deck with its popular Mileage Plan loyalty scheme. In a pitch to customers of both Alaska and Hawaiian Airlines, the carrier is rolling out its new Atmos Rewards plan.

Jake Goldenfein receives funding from the Australian Research Council Centre of Excellence for Automated Decision-Making and Society (ADM+S). This research was conducted with assistance from the ...